Chris Brown

Director of Group Finance at ECO ANIMAL HEALTH GROUP PLC
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Sandy, UK

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Director of Group Finance
      • Mar 2020 - Present

      ECO develops and markets branded veterinary pharmaceuticals worldwide. Invests £9m+ pa. in R&D. ECO is AIM listed, has 14 regional offices in strategic markets and utilises 3rd party manufacturers across the globe including China, UK and Canada. Revenues £106m and 200+ staff. Implemented appropriate financial controls for a fast growing AIM listed company. Including the selection and appointment of auditor BDO to strengthen corporate governance. Transitioned to electronic records and… Show more ECO develops and markets branded veterinary pharmaceuticals worldwide. Invests £9m+ pa. in R&D. ECO is AIM listed, has 14 regional offices in strategic markets and utilises 3rd party manufacturers across the globe including China, UK and Canada. Revenues £106m and 200+ staff. Implemented appropriate financial controls for a fast growing AIM listed company. Including the selection and appointment of auditor BDO to strengthen corporate governance. Transitioned to electronic records and new procedures ahead of Covid-19 which assisted moving the finance team to remote working with limited disruption. Rectified non-conformance with IFRS resulting in multiple restatements in FY20 accounts regarding revenue recognition (IFRS15), R&D capitalisation (IAS38), joint ventures (IFRS11), leases (IFRS16), treatment of bonuses, foreign exchange and options. Designed and recruited new Finance team to support future growth and maintain the new standard of working and reporting.

    • Interim Finance Director
      • May 2019 - Feb 2020

      London, United Kingdom Enhanced investor slides and presented financial sections during 7 days of shareholder meetings. Implementing process improvements, including quality of financial reporting and systems.

    • United Kingdom
    • Defense and Space Manufacturing
    • 300 - 400 Employee
    • Interim Finance Director
      • Jan 2019 - May 2019

      St. Neots, Cambridgeshire, United Kingdom Part of Cohort plc, MASS delivers cutting-edge technology solutions and tailored services that improve the security, efficiency and effectiveness of operations. Serving the defence, government, business and education markets in the UK and around the world. Supported the MD and senior leadership team. Responsible for financial reporting, integrity and processes of the business. Provided leadership and direction to Finance, IT, Commercial and Operations and project sponsored the… Show more Part of Cohort plc, MASS delivers cutting-edge technology solutions and tailored services that improve the security, efficiency and effectiveness of operations. Serving the defence, government, business and education markets in the UK and around the world. Supported the MD and senior leadership team. Responsible for financial reporting, integrity and processes of the business. Provided leadership and direction to Finance, IT, Commercial and Operations and project sponsored the implementation of Access ERP solution. Show less

    • Chief Financial Officer
      • Dec 2017 - Jan 2019

      Cambridge, United Kingdom Domainex Ltd. is a Cambridge-based, privately-owned company that provides expert chemistry and biology research services to global pharmaceutical, biotechnology and academic partners. Its services cover a wide span of the drug research value chain, from disease target selection to pre-clinical candidate nomination. Revenues £9m and 70+ staff. Initially appointed as CFO to support the Executive Chairman (no CEO) with growth strategy and communication with the senior executive team, Board… Show more Domainex Ltd. is a Cambridge-based, privately-owned company that provides expert chemistry and biology research services to global pharmaceutical, biotechnology and academic partners. Its services cover a wide span of the drug research value chain, from disease target selection to pre-clinical candidate nomination. Revenues £9m and 70+ staff. Initially appointed as CFO to support the Executive Chairman (no CEO) with growth strategy and communication with the senior executive team, Board and shareholders. I enhanced and helped present the investor deck to attract new funding (some VCT). I evaluated and completed due diligence of potential M&A targets. Supported the CEO (formally Chief Scientific Officer) with commercial strategy in response to changes in market. My role was both strategic and hands-on, completing Company Secretary duties through to full responsibilities for Finance, IT, Facilities and HR. Show less

    • Director
      • Mar 2017 - Nov 2017

      Sandy, Bedfordshire Brown FD Solutions provides financial leadership and commercial support to SME companies and larger international enterprises, on an interim or consulting basis.

    • United Kingdom
    • IT Services and IT Consulting
    • 200 - 300 Employee
    • Interim UK Finance Director
      • Mar 2017 - Oct 2017

      Wellingborough, Northants Misco was a leading provider of IT products, solutions and services to corporate businesses and public-sector organisations. Misco had trading operations in the UK, Netherlands, Italy, Spain and Sweden, supported by a Hungarian shared services centre. UK Turnover £170k and 300+ staff. As interim FD, I assisted the Executive team (partial owners of Misco Europe), following their March 2017 management buy in, with their strategies to raise new finance and reporting to the PE investors. I… Show more Misco was a leading provider of IT products, solutions and services to corporate businesses and public-sector organisations. Misco had trading operations in the UK, Netherlands, Italy, Spain and Sweden, supported by a Hungarian shared services centre. UK Turnover £170k and 300+ staff. As interim FD, I assisted the Executive team (partial owners of Misco Europe), following their March 2017 management buy in, with their strategies to raise new finance and reporting to the PE investors. I provided support and business modelling for cost saving projects, restructuring, funding requirements and growth opportunities. I monitored and forecasted the UK’s daily cash requirements, ensuring compliance with lender covenants and working with limited working capital, whilst burning cash, prior to turnaround. I created medium term business plans and management information for trade credit insurers, suppliers and customers, to reflect cost savings initiatives and turnaround strategy. Show less

    • United States
    • Research
    • 300 - 400 Employee
    • Senior Vice President Finance
      • 2014 - 2016

      Cambridgeshire, UK Envigo is a leading non-clinical Contract Research Organisation that offers mission-critical products and services to the pharmaceutical, chemical, and agrochemical industries, as well as academic and governmental institutions, through two business segments with revenues of just under $500 million, with 3,800+ employees and 35+ operating facilities in 10+ countries. As the Senior VP of Finance, I was responsible for the global finance team of over 100 employees in 10 countries across… Show more Envigo is a leading non-clinical Contract Research Organisation that offers mission-critical products and services to the pharmaceutical, chemical, and agrochemical industries, as well as academic and governmental institutions, through two business segments with revenues of just under $500 million, with 3,800+ employees and 35+ operating facilities in 10+ countries. As the Senior VP of Finance, I was responsible for the global finance team of over 100 employees in 10 countries across UK, US, Europe and Asia. I continuously developed business information to ensure my fellow members of Executive Leadership made the best decisions for both the short and long term strategy of the global company. I was an active member of the committee that successfully integrated the acquisition of a larger competitor, subsequent to performing the financial due diligence and preparing the original financial model justifying the investment. I developed the tax transfer pricing solutions for global intercompany trading, management fees and debt. I collected significant R&D cash credits following the initial application, subsequent refinements and negotiations with HMRC.

    • Finance Director
      • 2008 - 2014

      In the Finance Director role I was responsible for all finance functions across all locations, which also included tax, treasury, procurement and insurance. Coordinated due diligence reviews, supporting listings and marketing materials for bond sale on a public register, third party refinancing and public to privatisation proxy reporting Oversaw the upgrading of the Procurement function to generate measurable savings and improve supplier partnerships. Presented Employers… Show more In the Finance Director role I was responsible for all finance functions across all locations, which also included tax, treasury, procurement and insurance. Coordinated due diligence reviews, supporting listings and marketing materials for bond sale on a public register, third party refinancing and public to privatisation proxy reporting Oversaw the upgrading of the Procurement function to generate measurable savings and improve supplier partnerships. Presented Employers Covenant to the trustees of the underfunded defined benefit pension scheme to negotiate a revised contribution plan that also supported the company’s strategic investment opportunities

    • Group Financial Controller
      • 2005 - 2008

      In the Group Financial Controller role I was responsible for all listed SEC reporting under US GAAP including collection, consolidation, preparation of either quarterly 10Q or yearly 10K and the supporting investor reports. This responsibility also extended to statutory reporting and tax compliance for the local offices. To comply with SEC filing rules I introduced global, internal controls, SOX programme within a tight time frame, gaining external auditor certification and improving… Show more In the Group Financial Controller role I was responsible for all listed SEC reporting under US GAAP including collection, consolidation, preparation of either quarterly 10Q or yearly 10K and the supporting investor reports. This responsibility also extended to statutory reporting and tax compliance for the local offices. To comply with SEC filing rules I introduced global, internal controls, SOX programme within a tight time frame, gaining external auditor certification and improving accounting processes

    • Financial Controller
      • 2002 - 2004

      Cambridge, United Kingdom A dual listed (LSE FTSE 250 and NASDAQ) software development company. Turnover $60m, 230 staff and market capitalisation $400m.

    • Finance Director
      • 2001 - 2002

      London, United Kingdom A computer consultancy service company with turnover £1m, 10 staff and 20 consultants.

    • Advertising Services
    • 700 & Above Employee
    • International Procurement Director
      • 1998 - 2001

      London, United Kingdom Omnicom Group Inc. was the largest marketing and corporate communications company in the World with $7 billion revenues, 57,000+ employees and 1,500+ agencies in 100+ countries.

    • Assistant Controller
      • 1998 - 1998

      New York

    • International Treasury Finance Director
      • 1995 - 1998

      London, United Kingdom

    • Financial Controller
      • 1993 - 1995

      London, United Kingdom A public relations consultancy with £13m billings, £9m fee income, 200+ employees and subsidiary of advertising media group WPP Group plc.

    • Financial Accountant
      • 1991 - 1993

      London, United Kingdom

    • Audit Senior
      • 1987 - 1991

      London, United Kingdom

Education

  • Imperial College London
    Bachelor’s Degree, Mathematics
    1984 - 1987

Community

You need to have a working account to view this content. Click here to join now